Home
>
National Drug Code (NDC)
>
RELENZA
RELENZA - 0173-0681-01 - (zanamivir)
Drug Information of RELENZA
| Product NDC: | 0173-0681 |
| Proprietary Name: | RELENZA |
| Non Proprietary Name: | zanamivir |
| Active Ingredient(s): | 5 mg/1 & nbsp; zanamivir |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RELENZA
| Product NDC: | 0173-0681 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021036 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990922 |
Package Information of RELENZA
| Package NDC: | 0173-0681-01 |
| Package Description: | 5 PACKAGE in 1 CARTON (0173-0681-01) > 4 POWDER in 1 PACKAGE |
NDC Information of RELENZA
| NDC Code | 0173-0681-01 |
| Proprietary Name | RELENZA |
| Package Description | 5 PACKAGE in 1 CARTON (0173-0681-01) > 4 POWDER in 1 PACKAGE |
| Product NDC | 0173-0681 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zanamivir |
| Dosage Form Name | POWDER |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 19990922 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | ZANAMIVIR |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] |
